Correlation Between Aemetis and VanEck Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aemetis and VanEck Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aemetis and VanEck Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aemetis and VanEck Biotech ETF, you can compare the effects of market volatilities on Aemetis and VanEck Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aemetis with a short position of VanEck Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aemetis and VanEck Biotech.

Diversification Opportunities for Aemetis and VanEck Biotech

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Aemetis and VanEck is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Aemetis and VanEck Biotech ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VanEck Biotech ETF and Aemetis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aemetis are associated (or correlated) with VanEck Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VanEck Biotech ETF has no effect on the direction of Aemetis i.e., Aemetis and VanEck Biotech go up and down completely randomly.

Pair Corralation between Aemetis and VanEck Biotech

Given the investment horizon of 90 days Aemetis is expected to generate 11.75 times more return on investment than VanEck Biotech. However, Aemetis is 11.75 times more volatile than VanEck Biotech ETF. It trades about 0.12 of its potential returns per unit of risk. VanEck Biotech ETF is currently generating about -0.39 per unit of risk. If you would invest  307.00  in Aemetis on January 19, 2024 and sell it today you would earn a total of  59.00  from holding Aemetis or generate 19.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Aemetis  vs.  VanEck Biotech ETF

 Performance 
       Timeline  
Aemetis 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Aemetis are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Aemetis showed solid returns over the last few months and may actually be approaching a breakup point.
VanEck Biotech ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VanEck Biotech ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Etf's fundamental drivers remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders.

Aemetis and VanEck Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aemetis and VanEck Biotech

The main advantage of trading using opposite Aemetis and VanEck Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aemetis position performs unexpectedly, VanEck Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck Biotech will offset losses from the drop in VanEck Biotech's long position.
The idea behind Aemetis and VanEck Biotech ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios